青岛市新生儿脂肪酸氧化障碍性疾病筛查及基因分析

吕金峰, 王洪芹, 王伟青, 陈艳萍

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (8) : 941-946.

PDF(553 KB)
HTML
PDF(553 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (8) : 941-946. DOI: 10.7499/j.issn.1008-8830.2506067
论著·临床研究

青岛市新生儿脂肪酸氧化障碍性疾病筛查及基因分析

作者信息 +

Screening and genetic variation analysis of fatty acid oxidation disorder in neonates in Qingdao City

Author information +
文章历史 +

摘要

目的 调查青岛市新生儿脂肪酸氧化障碍性疾病(fatty acid oxidation disorder, FAOD)的发病率、基因突变特点和预后。 方法 收集青岛市新生儿疾病筛查中心2014—2023年确诊的FAOD患儿的临床资料,分析FAOD的发病率、基因型和预后。 结果 在562 225例新生儿中,共确诊42例FAOD患儿(6种亚型),总发病率为1/13 386。其中原发性肉碱缺乏症最常见(20例,48%),随访期间1例出现生长发育迟缓;中链酰基辅酶A脱氢酶缺乏症6例,随访期间患儿均发育良好;短链酰基辅酶A脱氢酶缺乏症5例,随访期间1例出现皮肤红斑、丘疹、鳞屑伴干燥;极长链酰基辅酶A脱氢酶缺乏症5例,随访期间1例死亡,1例反复出现横纹肌溶解;短/支链酰基辅酶A脱氢酶缺乏症4例,随访期间1例语言发育倒退;多种酰基辅酶A脱氢酶缺乏症2例,随访期间1例死亡,1例运动发育迟缓。对42例FAOD患儿中的37例行基因检测,结果显示SLC22A5基因c.1400C>G为原发性肉碱缺乏症患儿的热点突变,其余FAOD亚型未检出类似高频热点突变。 结论 青岛市新生儿FAOD以原发性肉碱缺乏症发病率最高,其热点突变为SLC22A5基因c.1400C>G。除极长链酰基辅酶A脱氢酶缺乏症和多种酰基辅酶A脱氢酶缺乏症外,其余亚型患儿大多预后良好。

Abstract

Objective To investigate the incidence, genetic mutation characteristics, and prognosis of fatty acid oxidation disorder (FAOD) in neonates in Qingdao. Methods Clinical data of neonates diagnosed with FAOD from 2014 to 2023 at the Qingdao Neonatal Disease Screening Center were collected and analyzed to determine the incidence, genotype, and prognosis. Results Among 562 225 neonates screened, 42 were diagnosed with FAOD across six types, yielding an overall incidence of 1/13 386. Primary carnitine deficiency was the most common (20 cases, 48%), with one case showing growth retardation during follow-up. Medium-chain acyl-CoA dehydrogenase deficiency was identified in 6 cases, all of whom demonstrated normal development during follow-up. Short-chain acyl-CoA dehydrogenase deficiency was diagnosed in 5 cases, with one case exhibiting skin erythema, papules, scaling, and dryness during follow-up. Very-long-chain acyl-CoA dehydrogenase deficiency was diagnosed in 5 cases; during follow-up, one patient died and another experienced recurrent rhabdomyolysis. Short/branched-chain acyl-CoA dehydrogenase deficiency was found in 4 cases, with one case showing language regression during follow-up. Multiple acyl-CoA dehydrogenase deficiency was detected in 2 cases; during follow-up, one patient died and one exhibited delayed motor development. Genetic testing performed on 37 of the 42 patients with FAOD identified a hotspot mutation, c.1400C>G, in the SLC22A5 gene among those with primary carnitine deficiency, whereas no predominant hotspot mutations were detected in other FAOD subtypes. Conclusions In Qingdao, primary carnitine deficiency is the most prevalent subtypes of FAOD in neonates, characterized by the hotspot mutation c.1400C>G in the SLC22A5 gene. Except for very-long-chain acyl-CoA dehydrogenase deficiency and multiple acyl-CoA dehydrogenase deficiency, most children with other FAOD subtypes have a favorable prognosis.

关键词

脂肪酸氧化障碍性疾病 / 新生儿筛查 / 基因诊断 / 新生儿

Key words

Fatty acid oxidation disorder / Newborn screening / Genetic diagnosis / Neonate

引用本文

导出引用
吕金峰, 王洪芹, 王伟青, . 青岛市新生儿脂肪酸氧化障碍性疾病筛查及基因分析[J]. 中国当代儿科杂志. 2026, 28(8): 941-946 https://doi.org/10.7499/j.issn.1008-8830.2506067
Jin-Feng LYU, Hong-Qin WANG, Wei-Qing WANG, et al. Screening and genetic variation analysis of fatty acid oxidation disorder in neonates in Qingdao City[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(8): 941-946 https://doi.org/10.7499/j.issn.1008-8830.2506067

参考文献

[1]
Guerra IMS, Ferreira HB, Melo T, et al. Mitochondrial fatty acid β-oxidation disorders: from disease to lipidomic studies—a critical review[J]. Int J Mol Sci, 2022, 23(22): 13933. PMCID: PMC9696092. DOI: 10.3390/ijms232213933 .
[2]
Vianey-Saban C, Guffon N, Fouilhoux A, et al. Fifty years of research on mitochondrial fatty acid oxidation disorders: the remaining challenges[J]. J Inherit Metab Dis, 2023, 46(5): 848-873. DOI: 10.1002/jimd.12664 .
[3]
Adeva-Andany MM, Carneiro-Freire N, Seco-Filgueira M, et al. Mitochondrial β-oxidation of saturated fatty acids in humans[J]. Mitochondrion, 2019, 46: 73-90. DOI: 10.1016/j.mito.2018.02.009 .
[4]
中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组. 新生儿筛查遗传代谢病诊治规范专家共识[J]. 中华新生儿科杂志(中英文), 2023, 38(7): 385-394. DOI: 10.3760/cma.j.issn.2096-2932.2023.07.001 .
[5]
中国妇幼保健协会儿童疾病与保健分会遗传代谢病学组, 陈晓红, 孙云, 等. 多种酰基辅酶A脱氢酶缺乏症的筛查与诊治共识[J]. 中华医学遗传学杂志, 2021, 38(5): 414-418. DOI: 10.3760/cma.j.cn511374-20200829-00630 .
[6]
中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组, 中华医学会儿科分会出生缺陷预防与控制专业委员会, 中国医师协会医学遗传医师分会临床生化遗传专业委员会, 等. 原发性肉碱缺乏症筛查与诊治共识[J]. 中华医学杂志, 2019, 99(2): 88-92. DOI: 10.3760/cma.j.issn.0376-2491.2019.02.003 .
[7]
卫生部临床检验中心新生儿遗传代谢疾病筛查室间质量评价委员会. 新生儿疾病串联质谱筛查技术专家共识[J]. 中华检验医学杂志, 2019, 42(2): 89-97. DOI: 10.3760/cma.j.issn.1009-9158.2019.02.004 .
[8]
Bayley N. Bayley Scales of Infant and Toddler Development[M]. 3rd ed. San Antonio, TX: Harcourt Assessment, 2006.
[9]
张秀玲, 李寄平, 秦明镜, 等. Gesell发展诊断量表3.5~6岁北京修订本的制定[J]. 中国临床心理学杂志, 1994, 2(3): 148-150.
[10]
张厚粲. 韦氏儿童智力量表第四版(WISC-IV)中文版的修订[J]. 心理科学, 2009, 32(5): 1177-1179.
[11]
Marsden D, Bedrosian CL, Vockley J. Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders[J]. Genet Med, 2021, 23(5): 816-829. PMCID: PMC8105167. DOI: 10.1038/s41436-020-01070-0 .
[12]
Lim JS, Tan ES, John CM, et al. Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): an 8 year journey from pilot to current program[J]. Mol Genet Metab, 2014, 113(1-2): 53-61. DOI: 10.1016/j.ymgme.2014.07.018 .
[13]
Maguolo A, Rodella G, Dianin A, et al. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: a single centre experience[J]. Mol Genet Metab Rep, 2020, 24: 100632. PMCID: PMC7414009. DOI: 10.1016/j.ymgmr.2020.100632 .
[14]
郑静, 张玉, 洪芳, 等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 248-255. PMCID: PMC10397024. DOI: 10.3785/j.issn.1008-9292.2017.06.04 .
[15]
杨池菊, 史彩虹, 周成, 等. 山东省济宁地区新生儿脂肪酸氧化代谢病筛查及随访分析[J]. 浙江大学学报(医学版), 2021, 50(4): 472-480. PMCID: PMC8714482. DOI: 10.3724/zdxbyxb-2021-0259 .
[16]
李霞, 何玲, 孙玉亭, 等. 长沙地区352 449例新生儿多种遗传代谢病的筛查结果分析[J]. 中华医学遗传学杂志, 2023, 40(9): 1075-1085. DOI: 10.3760/cma.j.cn511374-20220629-00441 .
[17]
陈敏, 尹一帆, 刘浩, 等. 重庆市新生儿脂肪酸氧化代谢病筛查及确诊患儿随访分析[J]. 浙江大学学报(医学版), 2022, 51(3): 290-297. PMCID: PMC9511477. DOI: 10.3724/zdxbyxb-2022-0218 .
[18]
唐诚芳, 谭敏沂, 谢婷, 等. 广州地区新生儿遗传代谢病串联质谱法筛查结果及筛查性能评估[J]. 浙江大学学报(医学版), 2021, 50(4): 463-471. PMCID: PMC8714483. DOI: 10.3724/zdxbyxb-2021-0260 .
[19]
Lin Y, Lin C, Lin B, et al. Newborn screening for fatty acid oxidation disorders in a southern Chinese population[J]. Heliyon, 2024, 10(1): e23671. PMCID: PMC10770602. DOI: 10.1016/j.heliyon.2023.e23671 .
[20]
谭建强, 陈大宇, 黄钧, 等. 广西中北部地区新生儿脂肪酸氧化障碍酰基肉碱谱筛查及基因检测[J]. 中华医学遗传学杂志, 2019, 36(11): 1067-1072. DOI: 10.3760/cma.j.issn.1003-9406.2019.11.003 .
[21]
Yang C, Zhou C, Xu P, et al. Newborn screening and diagnosis of inborn errors of metabolism: a 5-year study in an eastern Chinese population[J]. Clin Chim Acta, 2020, 502: 133-138. DOI: 10.1016/j.cca.2019.12.022 .
[22]
杨茹莱, 沈亚平, 陈迟, 等. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764. DOI: 10.19485/j.cnki.issn2096-5087.2022.08.002 .
[23]
李晓乐, 朱昕赟, 贾晨路, 等. 河南省原发性肉碱缺乏症的新生儿筛查及基因突变分析[J]. 中华医学遗传学杂志, 2019, 36(12): 1167-1170. DOI: 10.3760/cma.j.issn.1003-9406.2019.12.004 .
[24]
Wang X, Fang H. Clinical and gene analysis of fatty acid oxidation disorders found in neonatal tandem mass spectrometry screening[J]. Pharmgenomics Pers Med, 2023, 16: 577-587. PMCID: PMC10254624. DOI: 10.2147/PGPM.S402760 .
[25]
胡海利, 李卫东, 王燕, 等. 合肥市原发性肉碱缺乏症新生儿筛查及基因变异分析[J]. 临床儿科杂志, 2023, 41(10): 680-684. DOI: 10.12372/jcp.2023.22e1344 .
[26]
宫丽霏, 赵金琦, 刘伟, 等. 北京市原发性肉碱缺乏症的新生儿筛查及基因突变分析[J]. 中国实用儿科杂志, 2025, 40(3): 244-249. DOI: 10.19538/j.ek2025030610 .
[27]
耿国兴, 阳奇, 范歆, 等. 广西地区原发性肉碱缺乏症新生儿筛查代谢谱及基因变异分析[J]. 中华医学遗传学杂志, 2021, 38(11): 1051-1054. DOI: 10.3760/cma.j.cn511374-20200805-00586 .
[28]
Lee NC, Tang NL, Chien YH, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening[J]. Mol Genet Metab, 2010, 100(1): 46-50. DOI: 10.1016/j.ymgme.2009.12.015 .
[29]
Zhou J, Li G, Zeng Y, et al. Screening primary carnitine deficiency in 10 million Chinese newborns: a systematic review and meta-analysis[J]. Orphanet J Rare Dis, 2024, 19(1): 248. PMCID: PMC11220949. DOI: 10.1186/s13023-024-03267-x .
[30]
Wang B, Zhang Q, Gao A, et al. New ratios for performance improvement for identifying acyl-CoA dehydrogenase deficiencies in expanded newborn screening: a retrospective study[J]. Front Genet, 2019, 10: 811. PMCID: PMC6759686. DOI: 10.3389/fgene.2019.00811 .
[31]
Tucci S, Wagner C, Grünert SC, et al. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: are predictions possible?[J]. J Inherit Metab Dis, 2021, 44(4): 916-925. DOI: 10.1002/jimd.12368 .
[32]
曹金俊, 邱文娟, 章瑞南, 等. 极长链酰基辅酶A脱氢酶缺乏症11例的临床和ACADVL基因突变谱分析[J]. 中华儿科杂志, 2015, 53(4): 262-267. DOI: 10.3760/cma.j.issn.0578-1310.2015.04.007 .
[33]
Madsen PP, Kibaek M, Roca X, et al. Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A>G mutation that causes exon skipping[J]. Hum Genet, 2006, 118(6): 680-690. DOI: 10.1007/s00439-005-0070-4 .
[34]
Knebel LA, Zanatta Â, Tonin AM, et al. 2-Methylbutyrylglycine induces lipid oxidative damage and decreases the antioxidant defenses in rat brain[J]. Brain Res, 2012, 1478: 74-82. DOI: 10.1016/j.brainres.2012.08.039 .
[35]
蒋丽红, 吴本清, 赵正言. 二代测序在新生儿疾病早期筛查中的临床应用[J]. 中国当代儿科杂志, 2025, 27(4): 432-437. PMCID: PMC12011000. DOI: 10.7499/j.issn.1008-8830.2409107 .

脚注

所有作者均声明无利益冲突。


PDF(553 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/